Effects of Virtual Reality After Liver Transplantation
VR-LT
Effects of Virtual Reality on Pain, Fatigue and Vital Signs After Liver Transplantation A Randomized Controlled Trial
1 other identifier
interventional
84
1 country
1
Brief Summary
This randomized controlled study aims to evaluate the effects of a virtual reality intervention on pain, fatigue and vital signs in patients during the early postoperative period after liver transplantation. Postoperative symptoms such as pain and fatigue may negatively affect recovery and patient comfort. Virtual reality has emerged as a non-pharmacological method that may help reduce these symptoms by providing distraction and relaxation. A total of 84 patients were randomly assigned to an experimental group or a control group. The experimental group received a 20-minute virtual reality session, while the control group received standard care. Pain, fatigue and vital signs were measured before and after the intervention. This study aims to determine whether virtual reality can improve patient comfort and physiological stability and support recovery after liver transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedFirst Submitted
Initial submission to the registry
April 24, 2026
CompletedFirst Posted
Study publicly available on registry
May 7, 2026
CompletedMay 7, 2026
May 1, 2026
9 months
April 24, 2026
May 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in fatigue severity
Change in fatigue severity measured using the Brief Fatigue Inventory (BFI) total score (range: 0-10; higher scores indicate greater fatigue)
Baseline and 15 minutes after intervention
Secondary Outcomes (4)
Change in pain intensity
Baseline and 15 minutes after intervention
Change in heart rate (beats per minute)
Baseline and 15 minutes after intervention
Change in systolic and diastolic blood pressure (mmHg)
Baseline and 15 minutes after intervention
Change in systolic and diastolic blood pressure (mmHg)
Baseline and 15 minutes after intervention
Study Arms (2)
Experimental Group
EXPERIMENTALParticipants received a 20 minute virtual reality intervention during the early postoperative period following liver transplantation. The intervention was administered using a head mounted display and aimed to reduce fatigue and improve physiological parameters
Control Group
ACTIVE COMPARATORParticipants received routine postoperative care without any additional intervention
Interventions
A 20 minute immersive virtual reality session was administered using a headmounted display during the early postoperative period following liver transplantation.
Participants received routine postoperative care without any additional intervention
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Underwent liver transplantation
- In the early postoperative period
- Able to communicate verbally
- No diagnosed psychiatric disorder
- Hemodynamically stable
- Pain score ≥4 on the Numerical Rating Scale (NRS)
- Willing to participate in the study
You may not qualify if:
- Presence of severe postoperative complications
- Cognitive impairment or inability to understand instructions
- Visual or hearing impairments preventing use of virtual reality
- History of motion sickness or vertigo related to virtual reality use
- Chronic diseases that may affect fatigue or vital signs (e.g., uncontrolled cardiovascular or respiratory diseases)
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Inonu University Liver Transplantation Institute
Malatya, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors were blinded to group allocation. Participants and care providers were not blinded due to the nature of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
April 24, 2026
First Posted
May 7, 2026
Study Start
May 1, 2025
Primary Completion
January 31, 2026
Study Completion
January 31, 2026
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share